Antagonist-Elicited Cannabis Withdrawal

NCT01041170 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Cannabis
Dependence

Interventions

DRUG: THC
DRUG: Rimonobant
DRUG: Rimonabant

Sponsor

National Institute on Drug Abuse (NIDA)